Meeting Results of the Advisory Committee for the Safety and Efficacy Assessment of COVID-19 Therapeutics [Press Release, Jan 18, 2021]
- Registration Date 2021-02-03
- Hit 12503
[Press Release, Jan 18, 2021, unofficial translation]
Meeting Results of the Advisory Committee for the Safety and Efficacy Assessment of COVID-19 Therapeutics
- on the clinical test results of Celltrion’s monoclonal antibody therapeutics candidate (Regkirona Inj)
Division 국제협력담당관
Written by 배성명
Telephone 043-719-1559